Long-term serologic follow-up of isolated hepatitis b core antibody in hiv-infected and hiv-uninfected women

Clinical Infectious Diseases

Volumn 49, Issue 1, 2009, Pages 148-154

  French, Audrey L ^a,j   Lin, Michael Y ^a   Evans, Charlesnika T ^b,c   Benning, Lorie ^d   Glesby, Marshall J ^e   Young, Mary A ^g   Operskalski, Eva A ^h   Augenbraun, Michael ^f   Peters, Marion ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g GEORGETOWN UNIVERSITY   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Jr Hospital of Cook County   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; AGE DISTRIBUTION; ANTIBODY ISOLATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SELF REPORT; SEROCONVERSION; SEROLOGY; VACCINATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES;

EID: 66949165800     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599610     Document Type: Article

References (28)

1. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62:450-5.
2. Knoll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serologic pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J Gastroenterol 2006; 12:1255-60.
3. Tien PC, Kovacs A, Bacchetti P, et al. Association between syphilis, antibodies to herpes simplex virus type 2 and recreational drug use and hepatitis B infection in the Women's Interagency HIV Study. Clin Infect Dis 2004;39:1363-70.
4. Gandhi RT, Wurcel A, McGovern B, et al. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr 2003;34:439-41.
5. Piroth L, Binquet C, Vergne M, et al. The evolution of hepatitis B virus serological patterns and clinical relevance of isolated antibodies to hepatitis B core antigen in HIV-infected individuals. J Hepatol 2002;36: 681-6.
6. Drake JH, Parmley RT, Britton HA. Loss of hepatitis B antibody in HIV-positive hemophilia patients. Pediatr Infect Dis J 1987;6:1051-4.
7. Laukamm-Josten U, Miller O, Bienzle U, et al. Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men. AIDS 1988;2:400-1.
8. French AL, Operskalski E, Peters M, et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C infection in a cohort of US women. J Infect Dis 2007; 195:1437-42.
9. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology 1998;9:117-25.
10. Hessol NA, Schneider M, Greenblatt RM, et al. Retention of women enrolled in a prospective study of HIV infection: impact of race, unstable housing and use of HIV therapy. Am J Epidemiol 2001; 154: 563-73.
11. Tsui JI, French AL, Seaberg EC, et al. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007; 45:736-40.
12. Ismail N, Fish GE, Smith MB. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection ofHbsAg, antibodies to HBsAg and antibodies to hepatitis C virus. J Clin Mi- crobiol 2004;42:610-7.
13. La'ulu SL, Roberts WL. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 2006; 125:748-51.
14. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: http://aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL05042006050.pdf. Accessed 23 October 2008.
15. Sheng W-H, Kao J-H, Chen P-J, et al. Evolution of hepatitis B serologic markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007;45:1221-9.
16. Gandhi RT, Wurcel A, Lee H, et al. Response to hepatitis B vaccine in HIV-1 positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis 2005; 191:1435-41.
17. Wiedman M, Liebert UG, Oeson U, et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000;31:230-4.
18. Leroy V, Bourliere M, Durand M, et al. The antibody response to hepatitis B virus vaccination is negatively influence by the HCV viral load in patients with chronic hepatitis C: a case-control study. Eur J Gastroenterol Hepatol 2002; 14:485-9.
19. Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J. Antibodylevel after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C infection. Am J Nephrol 1996; 16:95-7.
20. Auffermann-Gretzinger S, Keeffe E, Levy S. Impaired dendritic cell maturation in patients with chronic but not resolved hepatitis C virus infection. Blood 2001;97:3171-6.
21. Anthony DD, Yonkers NL, Post AB, et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 2004; 172:4907-16.
22. Antonelli A, Ferri C, Galeazzi M, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008; 26(Suppl 48):S39-47.
23. Clifford BD, Donahue D, Smith L, et al. High prevalence of serologic markers of autoimmunity in patients with chronic hepatitis C. He- patology 1995;21:613-9.
24. Alisi A, Giannini C, Spaziani A, et al. Hepatitis C virus core protein enhances B lymphocyte proliferation. Dig Liver Dis 2007; 39:S72-5.
25. Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis C virus infection, cryoglobulinemia and beyond. Rheumatology 2007; 46:572-8.
26. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). II. Immunization ofadults. MMWR Recomm Rep 2006; 55(RR-16):1-33 (erratum: MMWRMorb Mortal Wkly Rep 2007; 56:1114).
27. Tedaldi EM, Baker RD, Moorman AC, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004; 38:1478-84.
28. Augenbraun M, Goedert JJ, Thomas D, et al. Incident hepatitis C virus infection in women with HIV: a report from the Women's Interagency HIV Study. Clin Infect Dis 2003;37:1357-64.